Gemma Salvadó

@gesalbla

Leader of the Neuroimaging group at @BarcelonaBeta & @fpmaragall /
Associate researcher at @biofinder_study, Lund University #Alzheimer #biomarkers

Joined September 2017

1.1K Following 1.6K Followers 896 Posts

Latest posts 5

Pinned post

Gemma Salvadó @gesalbla Sep 17, 2025

Happy to see this massive collaboration out covering 12 different cohorts including almost 3,000 cognitively unimpaired individuals.
Plasma p-tau217 can be used to detect preclinical Alzheimer’s, but positive predictive values increase if +ve results are confirmed with CSF or PET

BioFINDER @biofinder_study Sep 16, 2025

🚨Paper alert🚨
New publication in @JAMANeuro led by @gesalbla. In a multicentric study, we examined the clinical utility to assess preclinical #Alzheimer's disease in cognitively unimpaired individuals.
jamanetwork.com/journals/jaman…
A 🧵...
View quoted post on X

Gemma Salvadó @gesalbla Sep 22

Thank you for inviting me to participate in this great conference!

Fundación CIEN @Fund_CIEN Sep 22

Scientific Session II | Core 2 Biomarkers. Moderated by Michel Grothe, with Alexis Moscoso @idis_research, Gemma Salvadó @BarcelonaBeta / @lunduniversity & Laia Montoliu-Gaya @goteborgsuni. #ICNDSevilla2026

View quoted post on X

Gemma Salvadó @gesalbla Sep 21

Encantada de participar en la Noche de la Investigación este viernes en el en la sesión: "Alzhéimer: las defensas del cerebro, una nueva diana terapéutica"
Explicaremos cuándo y cómo las células que protegen nuestro cerebro pueden contribuir en la progresión de la enfermedad.

CaixaResearch Verified account @CaixaResearch Sep 21

🌙 Una noche para acercarte a la ciencia de forma diferente.

El 25 de septiembre, el @CosmoCaixa Barcelona se llena de investigadores, experimentos, talleres y charlas para todos los públicos.

📍 CosmoCaixa Barcelona | 🕕 18 h - 22 h

¡Ven a descubrirlo! tinyurl.com/tk54cpbm

View quoted post on X

Gemma Salvadó @gesalbla Sep 2

Great work from @Wiesje_Pelkmans who investigated the associations between CSF biomarkers related with multiple pathophysiological effects and change in gray matter volumes in early stages of AD
@BarcelonaBeta

Wiesje Pelkmans @Wiesje_Pelkmans Aug 27

Happy to share our latest work, published in @MolNeuro!
We studied associations between latent components from CSF #biomarkers with #longitudinal grey matter changes in preclinical AD, using data from @BarcelonaBeta and the @WisconsinADRC
@Raffaele_C1 @gesalbla @JuandoGispert
View quoted post on X

Gemma Salvadó @gesalbla Sep 2

A very special one, being the first as last author. And a tough one to get published.
Thanks to all coauthors but especially to Juan and @MontoliuGaya to make this journey easier.

BioFINDER @biofinder_study Sep 2

🔬 New work publication in Molecular Psychiatry!
In >2,000 BioFINDER participants, we show that CSF p-tau205 tracks Alzheimer’s disease progression and could contribute to biological staging, emerging later than Aβ42/40 and p-tau217 and closer to neocortical tau pathology.
View quoted post on X